Larvol Delta - ALPHA2-Safety-and-Efficacy-of-ALLO501A-AntiCD19-Allogeneic-CAR-T-Cells-in-Adults-With-RelapsedRefractory-Large-B-Cell-Lymphoma-Chronic-Lymphocytic-Leukemia-and-Small-Lymphocytic-Lymphoma-ALPHA2

cyclophosphamide - Generic mfg.

fludarabine IV - Generic mfg.

ALLO-647 - Allogene Overland Biopharm

cemacabtagene ansegedleucel (ALLO-501A) - Allogene Therap

http://clinicaltrials.gov/ct2/show/NCT04416984

Mar 5, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next